Antisense transcript associated to tumor cells having a T(14;18) translocation and oligodeoxynucleotides useful in the diagnosis and treatment of said tumor cells
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Dec 21, 1999
Grant Date -
N/A
app pub date -
Dec 15, 1997
filing date -
Mar 3, 1995
priority date (Note) -
Expired
status (Latency Note)
Importance
Loading Importance Indicators... 
Abstract
A chimeric bcl-2/IgH antisense transcript that hybridizes with the pre-mRNA of a hybrid gene in t(14;18) translocated cells. An ODN directed to complement any region of the above mentioned antisense transcript and the use thereof for diagnostic or therapeutic purposes.
Loading the Abstract Image...
OK
First Claim
Family
Loading Family data...
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully